2-methyl-5-(1-methylethenyl)cyclohexanol: fragrance ingredient; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
dihydrocarveol : A p-menthane monoterpenoid that is the dihydro derivative of carveol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 12072 |
| CHEBI ID | 50215 |
| SCHEMBL ID | 295511 |
| MeSH ID | M0528473 |
| Synonym |
|---|
| cyclohexanol, 2-methyl-5-(1-methylethenyl)- |
| p-menth-8-en-2-ol |
| einecs 210-575-1 |
| 1,6-dihydrocarveol |
| fema no. 2379 |
| 6-methyl-3-isopropenylcyclohexanol |
| 8-p-menthen-2-ol |
| 2-methyl-5-(1-methylethenyl)cyclohexanol |
| neodihydrocarveol |
| 5-isopropenyl-2-methylcyclohexanol |
| 2-methyl-5-isopropenylcyclohexanol |
| menth-8-en-2-ol |
| 2-methyl-5-(prop-1-en-2-yl)cyclohexanol |
| CHEBI:50215 |
| 619-01-2 |
| n-benzyl-2-[2-methyl-5-(4-methylphenyl)-2,3-dihydro-1,3,4-thiadiazol-2-yl]acetamide |
| dihydrocarveol |
| 38049-26-2 |
| 2-methyl-5-prop-1-en-2-ylcyclohexan-1-ol |
| C18017 |
| FT-0690209 |
| FT-0624953 |
| AKOS015906522 |
| gtpl6415 |
| SCHEMBL295511 |
| cyclohexanol, 2-methyl-5-(1-methylethenyl)-, (1r,2s,5s)-rel- |
| p-menth-8-en-2-ol, cis-1,2,trans-1,4- |
| (1r,2s,5s)-neodihydrocarveol |
| neocarveol, dihydro- |
| cyclohexanol, 2-methyl-5-(1-methylethenyl)-, (1.alpha.,2.alpha.,5.beta.)- |
| dihydro carveol neo |
| KRCZYMFUWVJCLI-UHFFFAOYSA-N |
| 5-isopropenyl-2-methylcyclohexanol, (1.alpha.,2.alpha.,5.beta.)- |
| cyclohexanol,2-methyl-5-(1-methylethenyl)- |
| mfcd00001503 |
| 2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol |
| FT-0771816 |
| DTXSID60862303 |
| FT-0774461 |
| Q1225152 |
| a dihydrocarveol |
| SB84645 |
| 1-dihydrocarveol |
| Role | Description |
|---|---|
| acaricide | A substance used to destroy pests of the subclass Acari (mites and ticks). |
| volatile oil component | Any plant metabolite that is found naturally as a component of a volatile oil. |
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| p-menthane monoterpenoid | |
| secondary alcohol | A secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (40.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3 (60.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||